Patent · US Active

Inhibition of tumor metastasis by anti-neuropilin 2 antibodies

US8920805B2 · kind B2 · utility

6Cited by
1References
38Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 11, 2013
Grant dateDec 30, 2014
Priority date—
Expiry dateJun 11, 2033

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides Nrp2 antagonists, such as anti-Nrp2 antibodies, and their use in the prevention and treatment of tumor metastasis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.